Show simple item record

Follow-up of aspirin-resistant patients with end-stage kidney disease

dc.contributor.authorOkcun, Baris
dc.contributor.authorAbaci, Okay
dc.contributor.authorGorcin, Bilal
dc.contributor.authorKilickesmez, Kadriye Orta
dc.contributor.authorKocas, Cuneyt
dc.contributor.authorGurmen, Tevfik
dc.date.accessioned2021-03-03T17:29:49Z
dc.date.available2021-03-03T17:29:49Z
dc.date.issued2013
dc.identifier.citationKilickesmez K. O. , Kocas C., Abaci O., Okcun B., Gorcin B., Gurmen T., "Follow-up of aspirin-resistant patients with end-stage kidney disease", INTERNATIONAL UROLOGY AND NEPHROLOGY, cilt.45, sa.4, ss.1097-1102, 2013
dc.identifier.issn0301-1623
dc.identifier.otherav_4a06476d-2547-4c48-b511-3f582e9ea6f1
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/53195
dc.identifier.urihttps://doi.org/10.1007/s11255-012-0217-x
dc.description.abstractAspirin resistance is defined by platelet function testing and presumed clinical unresponsiveness to aspirin. Aspirin-resistant patients are at a greater risk of clinically important adverse cardiovascular events. We aimed to investigate whether end-stage renal disease patients with aspirin resistance are at increased risk for long-term major adverse clinical events.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectNefroloji
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectÜROLOJİ VE NEFROLOJİ
dc.titleFollow-up of aspirin-resistant patients with end-stage kidney disease
dc.typeMakale
dc.relation.journalINTERNATIONAL UROLOGY AND NEPHROLOGY
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume45
dc.identifier.issue4
dc.identifier.startpage1097
dc.identifier.endpage1102
dc.contributor.firstauthorID210255


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record